Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass. These cancerous cells have the ability to invade other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and the term "pancreatic cancer" is sometimes used to refer only to that type. These adenocarcinomas start within the part of the pancreas that makes digestive enzymes. Several other types of cancer, which collectively represent the majority of the no adenocarcinomas, can also arise from these cells. About 1-2% of cases of pancreatic cancer are neuroendocrine tumors, which arise from the hormone-producing cells of the pancreas. These are generally less aggressive than pancreatic adenocarcinoma.
This report aims to provide a comprehensive presentation of the global market for Pancreatic Cancer Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pancreatic Cancer Diagnostic. This report contains market size and forecasts of Pancreatic Cancer Diagnostic in global, including the following market information:
Global Pancreatic Cancer Diagnostic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pancreatic Cancer Diagnostic market was valued at US$ 5879.4 million in 2022 and is projected to reach US$ 9432.5 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Pancreatic Cancer Diagnostic main manufactuers include Siemens, GE Healthcare, Roche, Philips Healthcare, totally accounting for 15% of the market. North America is the largest market, with a share about 40%. As for the types of products, it can be divided into imaging, tumor biomarker, biopsy and others. The most common type is imaging, with a share over 63%. As for the types of applications, it is widely used in hospitals, clinics and others. The most common application is in hospitals, with a share over 45%.
We surveyed the Pancreatic Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic Cancer Diagnostic Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pancreatic Cancer Diagnostic Market Segment Percentages, by Type, 2022 (%)
Imaging
Tumor Biomarker
Biopsy
Others
Global Pancreatic Cancer Diagnostic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pancreatic Cancer Diagnostic Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Pancreatic Cancer Diagnostic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pancreatic Cancer Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pancreatic Cancer Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pancreatic Cancer Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siemens
GE Healthcare
Roche
Philips Healthcare
Danaher
Canon Medical Systems
Abbott
Hitachi Medical
Qiagen
Myriad Genetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pancreatic Cancer Diagnostic, market overview.
Chapter 2: Global Pancreatic Cancer Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Pancreatic Cancer Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pancreatic Cancer Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pancreatic Cancer Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic Cancer Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic Cancer Diagnostic Overall Market Size
2.1 Global Pancreatic Cancer Diagnostic Market Size: 2022 VS 2029
2.2 Global Pancreatic Cancer Diagnostic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pancreatic Cancer Diagnostic Players in Global Market
3.2 Top Global Pancreatic Cancer Diagnostic Companies Ranked by Revenue
3.3 Global Pancreatic Cancer Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic Cancer Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pancreatic Cancer Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Pancreatic Cancer Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pancreatic Cancer Diagnostic Market Size Markets, 2022 & 2029
4.1.2 Imaging
4.1.3 Tumor Biomarker
4.1.4 Biopsy
4.1.5 Others
4.2 By Type - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Pancreatic Cancer Diagnostic Revenue, 2018-2023
4.2.2 By Type - Global Pancreatic Cancer Diagnostic Revenue, 2024-2029
4.2.3 By Type - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic Cancer Diagnostic Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Pancreatic Cancer Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global Pancreatic Cancer Diagnostic Revenue, 2024-2029
5.2.3 By Application - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pancreatic Cancer Diagnostic Market Size, 2022 & 2029
6.2 By Region - Global Pancreatic Cancer Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Pancreatic Cancer Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global Pancreatic Cancer Diagnostic Revenue, 2024-2029
6.2.3 By Region - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pancreatic Cancer Diagnostic Revenue, 2018-2029
6.3.2 US Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.3.3 Canada Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.3.4 Mexico Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pancreatic Cancer Diagnostic Revenue, 2018-2029
6.4.2 Germany Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.3 France Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.4 U.K. Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.5 Italy Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.6 Russia Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.7 Nordic Countries Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.4.8 Benelux Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pancreatic Cancer Diagnostic Revenue, 2018-2029
6.5.2 China Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.5.3 Japan Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.5.4 South Korea Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.5.5 Southeast Asia Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.5.6 India Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pancreatic Cancer Diagnostic Revenue, 2018-2029
6.6.2 Brazil Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.6.3 Argentina Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, 2018-2029
6.7.2 Turkey Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.7.3 Israel Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.7.4 Saudi Arabia Pancreatic Cancer Diagnostic Market Size, 2018-2029
6.7.5 UAE Pancreatic Cancer Diagnostic Market Size, 2018-2029
7 Pancreatic Cancer Diagnostic Companies Profiles
7.1 Siemens
7.1.1 Siemens Company Summary
7.1.2 Siemens Business Overview
7.1.3 Siemens Pancreatic Cancer Diagnostic Major Product Offerings
7.1.4 Siemens Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Siemens Key News & Latest Developments
7.2 GE Healthcare
7.2.1 GE Healthcare Company Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Pancreatic Cancer Diagnostic Major Product Offerings
7.2.4 GE Healthcare Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.2.5 GE Healthcare Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pancreatic Cancer Diagnostic Major Product Offerings
7.3.4 Roche Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Philips Healthcare
7.4.1 Philips Healthcare Company Summary
7.4.2 Philips Healthcare Business Overview
7.4.3 Philips Healthcare Pancreatic Cancer Diagnostic Major Product Offerings
7.4.4 Philips Healthcare Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Philips Healthcare Key News & Latest Developments
7.5 Danaher
7.5.1 Danaher Company Summary
7.5.2 Danaher Business Overview
7.5.3 Danaher Pancreatic Cancer Diagnostic Major Product Offerings
7.5.4 Danaher Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Danaher Key News & Latest Developments
7.6 Canon Medical Systems
7.6.1 Canon Medical Systems Company Summary
7.6.2 Canon Medical Systems Business Overview
7.6.3 Canon Medical Systems Pancreatic Cancer Diagnostic Major Product Offerings
7.6.4 Canon Medical Systems Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.6.5 Canon Medical Systems Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Pancreatic Cancer Diagnostic Major Product Offerings
7.7.4 Abbott Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Hitachi Medical
7.8.1 Hitachi Medical Company Summary
7.8.2 Hitachi Medical Business Overview
7.8.3 Hitachi Medical Pancreatic Cancer Diagnostic Major Product Offerings
7.8.4 Hitachi Medical Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Hitachi Medical Key News & Latest Developments
7.9 Qiagen
7.9.1 Qiagen Company Summary
7.9.2 Qiagen Business Overview
7.9.3 Qiagen Pancreatic Cancer Diagnostic Major Product Offerings
7.9.4 Qiagen Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Qiagen Key News & Latest Developments
7.10 Myriad Genetics
7.10.1 Myriad Genetics Company Summary
7.10.2 Myriad Genetics Business Overview
7.10.3 Myriad Genetics Pancreatic Cancer Diagnostic Major Product Offerings
7.10.4 Myriad Genetics Pancreatic Cancer Diagnostic Revenue in Global Market (2018-2023)
7.10.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pancreatic Cancer Diagnostic Market Opportunities & Trends in Global Market
Table 2. Pancreatic Cancer Diagnostic Market Drivers in Global Market
Table 3. Pancreatic Cancer Diagnostic Market Restraints in Global Market
Table 4. Key Players of Pancreatic Cancer Diagnostic in Global Market
Table 5. Top Pancreatic Cancer Diagnostic Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pancreatic Cancer Diagnostic Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pancreatic Cancer Diagnostic Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pancreatic Cancer Diagnostic Product Type
Table 9. List of Global Tier 1 Pancreatic Cancer Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Cancer Diagnostic Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pancreatic Cancer Diagnostic Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pancreatic Cancer Diagnostic Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pancreatic Cancer Diagnostic Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2024-2029
Table 30. Siemens Company Summary
Table 31. Siemens Pancreatic Cancer Diagnostic Product Offerings
Table 32. Siemens Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 33. Siemens Key News & Latest Developments
Table 34. GE Healthcare Company Summary
Table 35. GE Healthcare Pancreatic Cancer Diagnostic Product Offerings
Table 36. GE Healthcare Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 37. GE Healthcare Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Pancreatic Cancer Diagnostic Product Offerings
Table 40. Roche Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Philips Healthcare Company Summary
Table 43. Philips Healthcare Pancreatic Cancer Diagnostic Product Offerings
Table 44. Philips Healthcare Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 45. Philips Healthcare Key News & Latest Developments
Table 46. Danaher Company Summary
Table 47. Danaher Pancreatic Cancer Diagnostic Product Offerings
Table 48. Danaher Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 49. Danaher Key News & Latest Developments
Table 50. Canon Medical Systems Company Summary
Table 51. Canon Medical Systems Pancreatic Cancer Diagnostic Product Offerings
Table 52. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 53. Canon Medical Systems Key News & Latest Developments
Table 54. Abbott Company Summary
Table 55. Abbott Pancreatic Cancer Diagnostic Product Offerings
Table 56. Abbott Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 57. Abbott Key News & Latest Developments
Table 58. Hitachi Medical Company Summary
Table 59. Hitachi Medical Pancreatic Cancer Diagnostic Product Offerings
Table 60. Hitachi Medical Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 61. Hitachi Medical Key News & Latest Developments
Table 62. Qiagen Company Summary
Table 63. Qiagen Pancreatic Cancer Diagnostic Product Offerings
Table 64. Qiagen Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 65. Qiagen Key News & Latest Developments
Table 66. Myriad Genetics Company Summary
Table 67. Myriad Genetics Pancreatic Cancer Diagnostic Product Offerings
Table 68. Myriad Genetics Pancreatic Cancer Diagnostic Revenue (US$, Mn) & (2018-2023)
Table 69. Myriad Genetics Key News & Latest Developments
List of Figures
Figure 1. Pancreatic Cancer Diagnostic Segment by Type in 2022
Figure 2. Pancreatic Cancer Diagnostic Segment by Application in 2022
Figure 3. Global Pancreatic Cancer Diagnostic Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pancreatic Cancer Diagnostic Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pancreatic Cancer Diagnostic Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pancreatic Cancer Diagnostic Revenue in 2022
Figure 8. By Type - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 16. US Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 20. Germany Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 21. France Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 28. China Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 32. India Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 34. Brazil Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pancreatic Cancer Diagnostic Revenue Market Share, 2018-2029
Figure 37. Turkey Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pancreatic Cancer Diagnostic Revenue, (US$, Mn), 2018-2029
Figure 41. Siemens Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GE Healthcare Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Philips Healthcare Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Danaher Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Canon Medical Systems Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbott Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hitachi Medical Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Qiagen Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Myriad Genetics Pancreatic Cancer Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
